Table 2.
Risk classification by genetic platforms.
| Genetic test n (%) | Risk classification |
|---|---|
| OncotypeDx® (49%) | RS low (62,7%) RS intermédiate (27,7%) RS high (9,5%) |
| Mammaprint® (51%) | High (38,4%) Low (61,6%) |
Risk classification by genetic platforms.
| Genetic test n (%) | Risk classification |
|---|---|
| OncotypeDx® (49%) | RS low (62,7%) RS intermédiate (27,7%) RS high (9,5%) |
| Mammaprint® (51%) | High (38,4%) Low (61,6%) |